HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
VEGF Trap in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Phase I Study of Aprotinin in Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase I Combination w/ Epirubicin
- Status
- COMPLETED
- Phase
- PHASE1
Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
- Status
- COMPLETED
- Phase
- PHASE2
Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
- Status
- COMPLETED
- Phase
- PHASE2